InvestSMART

PharmX Technologies Limited (ASX: PHX) - Announcements

Current share price for PHX : $0.075 0.005 (7.14%)+

ASX company news and announcements for PharmX Technologies Limited (PHX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmX Technologies Limited (PHX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmX Technologies Limited (PHX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmX Technologies Limited (PHX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$50 Change of Company Secretary 27 Oct 2026 3:42PM $0.070 $0.075 risen by 7.14%
$50 Notice of Annual General Meeting & Proxy Form 23 Oct 2026 9:32AM $0.072 $0.075 risen by 4.17%
$50 Initial Director's Interest Notice - T Culver 21 Oct 2026 3:38PM $0.070 $0.075 risen by 7.14%
$50 Director Appointment 16 Oct 2026 9:48AM $0.084 $0.075 fallen by 10.71%
$50 Q1 FY27 Investor Presentation 14 Oct 2026 9:46AM $0.084 $0.075 fallen by 10.71%
$50 Q1 FY27 Investor Update 12 Oct 2026 9:58AM $0.089 $0.075 fallen by 15.73%
$50 Q1 FY27 Update 7 Oct 2026 9:14AM $0.096 $0.075 fallen by 21.88%
$50 Cleansing Notice 2 Oct 2026 4:58PM $0.096 $0.075 fallen by 21.88%
$50 Application for quotation of securities - PHX 29 Sep 2026 5:53PM $0.093 $0.075 fallen by 19.35%
$50 Notification regarding unquoted securities - PHX 29 Sep 2026 5:52PM $0.093 $0.075 fallen by 19.35%
$50 Notification of cessation of securities - PHX 29 Sep 2026 5:49PM $0.093 $0.075 fallen by 19.35%
$50 Pharmx to present at Coffee Microcaps Sydney Conference 22 Sep 2026 10:00AM $0.091 $0.075 fallen by 17.58%
$50 2026 Annual General Meeting - Key Dates 21 Sep 2026 11:19AM $0.090 $0.075 fallen by 16.67%
$50 FY26 Results Presentation 27 Aug 2026 8:57AM $0.105 $0.075 fallen by 28.57%
$50 Announcement of FY26 Results 27 Aug 2026 8:56AM $0.105 $0.075 fallen by 28.57%
$50 Appendix 4G & FY26 Corporate Governance Statement 27 Aug 2026 8:54AM $0.105 $0.075 fallen by 28.57%
$50 Appendix 4E & FY26 Annual Report 27 Aug 2026 8:53AM $0.105 $0.075 fallen by 28.57%
$50 Notice of FY26 Results Announcement 20 Aug 2026 10:36AM $0.105 $0.075 fallen by 28.57%
$50 Cleansing Notice 10 Jul 2026 4:01PM $0.120 $0.075 fallen by 37.50%
$50 Application for quotation of securities - PHX 10 Jul 2026 3:56PM $0.120 $0.075 fallen by 37.50%
$50 Sigma Healthcare 10% strategic holding now complete 10 Jul 2026 3:52PM $0.120 $0.075 fallen by 37.50%
$50 Pharmx Renews National NDSS Agreement 7 Jul 2026 9:12AM $0.110 $0.075 fallen by 31.82%
$50 Agreement of first work item under Sigma Strategic Alliance 29 Jun 2026 9:53AM $0.130 $0.075 fallen by 42.31%
$50 Notice of Investor Presentation 17 Jun 2026 9:52AM $0.115 $0.075 fallen by 34.78%
$50 Q3 Investor Update FY2026 5 May 2026 11:46AM $0.087 $0.075 fallen by 13.79%

1 - 25 of 111 results

Page 1 of 5

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.